PATENT CLAIM ANALYSIS

Application Number: 16269146
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["546", "159000"]

Abstract:
Compounds and compositions for selectively inhibiting Akt3 are provided. Methods of using the compounds are also provided. Because Akt3 modulates the suppressive function of natural Tregs and the polarization of induced Tregs, the disclosed compounds are useful for modulating immune responses.

Claim (Index 3):
A method of decreasing an immune suppressive response in a subject in need thereof comprising administering to the subject a composition comprising one or more compounds according to  claim 1  that selectively inhibits Akt3 by an amount effective to reduce the immune suppressive response in the subject.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 99.0
- Lexical Diversity: 1.5
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15407600', '15407659', '15900077', '14689517', '14679497']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7912577113972178
- 35 USC 102 Novelty (BERT): 0.6409413623678183
- Combined Prediction Score: 0.7762260764942779
- Mean Citation Score: 478.527102
- Max Citation Score: 603.2253400000002
- Similarity Product: 601.4081367221179

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test